Nuclear Medicine and Biology
Volume 36, Issue 7 , Pages 801-809 , October 2009

Imaging of peripheral-type benzodiazepine receptor in tumor: in vitro binding and in vivo biodistribution of N-benzyl-N-[11C]methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide

  • Tomoteru Yamasaki

      Affiliations

    • Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • ,
  • Katsushi Kumata

      Affiliations

    • Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • ,
  • Kazuhiko Yanamoto

      Affiliations

    • Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • ,
  • Akiko Hatori

      Affiliations

    • Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • ,
  • Makoto Takei

      Affiliations

    • Tokyo Nuclear Service Co. Ltd., Tokyo 141-8686, Japan
    • ,
  • Yukio Nakamura

      Affiliations

    • Tokyo Nuclear Service Co. Ltd., Tokyo 141-8686, Japan
    • ,
  • Sachiko Koike

      Affiliations

    • Heavy-ion Radiobiology Research Group, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • ,
  • Koichi Ando

      Affiliations

    • Heavy-ion Radiobiology Research Group, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • ,
  • Kazutoshi Suzuki

      Affiliations

    • Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • ,
  • Ming-Rong Zhang

      Affiliations

    • Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • Corresponding Author InformationCorresponding author. Radiochemistry Section, Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan. Tel.: +81 43 206 4041; fax: +81 43 206 3261.

Received 20 February 2009 ,Revised 30 April 2009 ,Accepted 12 May 2009.

References 

  1. Diederichs CG, Staib G, Glatting G, Beger HG, Reske SN. FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med. 1998;39:1030–1033
  2. Braestrup C, Albrechtsen R, Squires RF. High densities of benzodiazepine receptors in human cortical areas. Nature. 1977;269:702–704
  3. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère LL, Lindemann P, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Pharmacol Sci. 2006;27:402–409
  4. Black KL, Ikezaki K, Santori E, Becker DP, Vinters HV. Specific high-affinity binding of Peripheral benzodiazepine receptor ligands to brain tumors in rat and man. Cancer. 1990;65:93–97
  5. Cornu P, Benavides J, Scatton B, Hauw JJ, Philippon J. Increase in omega 3 (Peripheral-type benzodiazepine) binding site densities in different types of human brain tumors. A quantitative autoradiography study. Acta Neurochir. 1992;19:146–152
  6. Miettinen H, Kononen J, Haapasalo H, Helén P, Sallinen P, Harjunausta T, et al. Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res. 1995;5:2691–2695
  7. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 1999;59:831–842
  8. Galiègue S, Casellas P, Kramar A, Tinel N, Lafontaine JS. Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival. Clin Cancer Res. 2004;10:2058–2064
  9. Katz Y, Eitan A, Gavish M. Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology. 1990;47:139–142
  10. Deane NG, Manning HC, Foutch AC, Washington MK, Aronow BA, Bornhop DJ, et al. Targeted imaging of colonic tumors in smad3/mice discriminates cancer and inflammation. Mol Cancer Res. 2007;5:341–349
  11. Venturini I, Zeneroli ML, Corsi L, Avallone R, Farina F, Alho H, et al. Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci. 1998;63:1269–1280
  12. Costa B, Salvetti A, Rosssi L, Spinetti F, Lena A, Chelli B, et al. Peripheral benzodiazepine receptor: characterization in human T-lymphoma jurkat cells. Mol Pharmacol. 2006;69:37–44
  13. Momosaki S, Hosoi R, Takai N, Antony G, Inoue O. The apparent positive cooperatively of in vivo [3H]PK-11195 binding in mouse fibrosarcoma. Nucl Med Biol. 2006;33:797–800
  14. Santidrian AF, Cosialls AM, Coll-Mulet L, Iglesoas-Serret D, de Frias M, Gonzáles-Gironès DM, et al. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells. Haematologica. 2007;92:1631–1638
  15. Furre IE, Shahzidi S, Luksiene Z, Møller MT, Borqen E, Morgan J, et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res. 2005;65:11051–11060
  16. Walter RB, Pirga JL, Cronk MR, Mayer S, Appelbaum FR, Banker DE. PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism. Blood. 2005;106:3584–3593
  17. Pappata S, Cornu P, Samson Y, Prenant C, Benavides J, Scatton B, et al. PET study of carbon-11-PK11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J Nucl Med. 1991;32:1608–1610
  18. Kita A, Kohayakawa H, Kinoshita T, Ochi Y, Nakamichi K, Kurumiya S, et al. Antianxienty and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Bri J Phamacol. 2004;142:1059–1072
  19. Amitani M, Zhang MR, Noguchi J, Kumata K, Ito T, Takai N, et al. Blood flow dependence of the intratumoral distribution of peripheral benzodiazepine receptor binding in intact mouse fibrosarcoma. Nucl Med Biol. 2006;33:971–975
  20. Zhang MR, Kumata K, Maeda J, Yanamoto K, Hatori A, Okada M, et al. 11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain. J Nucl Med. 2007;48:1853–1861
  21. Manning HC, Smith SM, Sexton M, Haviland S, Bai M, Cederquist K, et al. A peripheral benzodiazepine receptor targeted agent for in vitro imaging and screening. Bioconjug Chem. 2006;17:735–740
  22. Kozikowski AP, Kotoula M, Ma D, Boujrad N, Tückmantel W, Papadopoulos V. Synthesis and biology of a 7-nitro-2,1,3-benaoxadiazol-4-yl derivative of 2-phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptor. J Med Chem. 1997;40:2435–2439
  23. Murata A, Masumoto K, Kondo K, Furukawa K, Oka M. inventors; Dainippon Sumitomo Pharma Co., Ltd., assignee. February 20, 2001. 2-Aryl-8-oxodihydropurine derivatives. Japanese patent JP 2001-48882A.
  24. Ando K, Koike S, Sato S. Nonlinear survival curves for cells of solid tumors after large doses of fast neutrons and γ rays. Radiat Res. 1992;131:157–161
  25. Ji B, Maeda J, Sawada M, Ono M, Okauchi T, Inaji M, et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J Neurosci. 2008;28:12255–12267
  26. Keyes JW. SUV: standard uptake or silly useless value?. J Nucl Med. 1995;36:1836–1839
  27. Hashimoto K, Inoue O, Suzuki K, Yamasaki T, Kojima M. Synthesis and evaluation of 11C-PK11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Annal Nucl Med. 1989;3:63–71
  28. Tsujii H, Morita S, Miyamoto T, Mizoe J, Mukai M, Nakano T, et al. Preliminary results of phase I/II carbon-ion therapy at the national institute of radiation sciences. J Brachythera Int. 1997;13:1–8
  29. Ando K, Koike S, Ohira C, Chen YJ, Nojima K, Ando S, et al. Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation. Int J Radiat Biol. 1999;75:505–512
  30. Koike S, Ando K, Oohira C, Fukawa T, Lee R, Takai N, et al. Relative biological effectiveness of 290 MeV/u carbon ions for the growth delay of a radioresistant murine fibrosarcoma. J Radiat Res. 2002;43:247–255
  31. Ando K, Koike S, Uzawa A, Takai N, Fukawa T, Furusawa Y, et al. Biological gain of carbon-ion radiation for the early response of tumor growth delay and against early response of skin reaction in mice. J Radiat Res. 2005;46:51–57
  32. Gavish M, Bachman I, Shoukrun R. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999;51:629–650
  33. Anholt RR, De Souza EB, Oster-Granite ML, Synder SH. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J Pharmacol Exp Ther. 1985;233:517–526
  34. Zhang MR, Kida T, Noguchi J, Furutsuka K, Maeda J, Suhara T, et al. [11C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol. 2003;30:513–519
  35. Zhang H, Yoshikawa K, Tamura K, Tomemori T, Sagou K, Tian M, et al. [11C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy. Clin Cancer Res. 2004;10:1764–1772

PII: S0969-8051(09)00128-0

doi: 10.1016/j.nucmedbio.2009.05.002

Nuclear Medicine and Biology
Volume 36, Issue 7 , Pages 801-809 , October 2009

Article Tools

* Image Usage & Resolution